Last reviewed · How we verify
NCT06573840
A Functional MRI Study: Assessing Brain Function in Post Stoke Patients
NA trial testing NeuroGlove in Ischemic Stroke. Withdrawn.
14 November 2024
Quick facts
| Lead sponsor | NeuroGlove LLC |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Start date | 10 November 2024 |
| Primary completion | 14 November 2024 |
| Estimated completion | 15 November 2024 |
Drugs / interventions tested
- NeuroGlove
Conditions studied
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Stroke — all drugs for Stroke →
- Acute Ischemic Stroke — all drugs for Acute Ischemic Stroke →
Sponsor
NeuroGlove LLC
Who can join
Adults 18 to 85, any sex, with Ischemic Stroke or Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, single center, observational clinical study containing two cohorts the healthy cohort and post stroke cohort. A total of 13 subjects will be enrolled. Three (3) healthy volunteers will be enrolled in the healthy cohort. Ten (10) subjects who have recently experienced a mild to moderate acute ischemic stroke will be enrolled in the post stroke cohort.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06573840
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NeuroGlove
Trials testing the same drug.
- NCT05961293 — NeuroGlove fMRI Study · NA · unknown
- NCT06578273 — NeuroGlove PD Study Clinical · EARLY_PHASE1 · completed
- NCT06065787 — NeuroGlove Anxiety and Depression Study · NA · unknown
- NCT06050590 — NeuroGlove PTSD Study · NA · unknown
Other recruiting trials for Ischemic Stroke
Currently open trials in the same condition.
- NCT07509645 — Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Post · Phase 3 · recruiting
- NCT07375953 — Repeated Intravenous Thrombolysis for Ischemic Stroke Within 3.0 Hours of Onset With Tenecteplase (RITIS-TNK) · Phase 2 · recruiting
- NCT07375966 — Repeated Intravenous Thrombolysis for Ischemic Stroke With Medium to Large Vessel Occlusion Presenting Within 4.5 Hours · Phase 2 · recruiting
- NCT07491952 — Continuous Dual Aspiration Technique With Zoom System for Stroke · recruiting
- NCT07371455 — A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LWP779 in Healthy Participants · Phase 1 · recruiting
Other NeuroGlove LLC trials
Trials by the same sponsor.
- NCT05961293 — NeuroGlove fMRI Study · NA · unknown
- NCT06578273 — NeuroGlove PD Study Clinical · EARLY_PHASE1 · completed
- NCT06065787 — NeuroGlove Anxiety and Depression Study · NA · unknown
- NCT06050590 — NeuroGlove PTSD Study · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06573840 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NeuroGlove LLC
- Last refreshed: 27 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06573840.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing